XML 49 R37.htm IDEA: XBRL DOCUMENT v3.25.1
Fair Value of Measurements (Tables)
3 Months Ended
Mar. 31, 2025
Fair Value Disclosures [Abstract]  
Assets and Liabilities Measured at Fair Value on Recurring Basis

The Company’s assets and liabilities measured at fair value on a recurring basis at March 31, 2025 and December 31, 2024, were as follows:

Fair Value Measurement at March 31, 2025 Using

    

    

Quoted Prices in

    

Significant

    

Active Markets

Other

Significant

for Identical

Observable

Unobservable

Assets

Inputs

Inputs

Total

(Level 1)

(Level 2)

(Level 3)

Interest rate swap derivative instruments – net asset position

$

9,458

$

$

9,458

$

Restricted cash

$

138,220

$

138,220

$

$

Restricted investments

$

73,973

$

$

73,973

$

Contingent consideration

$

(75,262)

$

$

$

(75,262)

Fair Value Measurement at December 31, 2024 Using

    

    

Quoted Prices in

    

Significant

    

Active Markets

Other

Significant

for Identical

Observable

Unobservable

Assets

Inputs

Inputs

Total

(Level 1)

(Level 2)

(Level 3)

Interest rate swap derivative instruments – net asset position

$

13,929

$

$

13,929

$

Restricted cash

$

135,807

$

135,807

$

$

Restricted investments

$

77,900

$

$

77,900

$

Contingent consideration

$

(87,162)

$

$

$

(87,162)

Fair Value for Level 3 Liabilities

The following table summarizes the changes in the fair value for Level 3 liabilities related to contingent consideration for the three months ended March 31, 2025 and 2024:

Three Months Ended March 31, 

    

2025

    

2024

    

Beginning balance

$

87,162

$

115,030

Contingent consideration recorded at acquisition date

 

8,864

 

12,012

Payment of contingent consideration recorded at acquisition date

 

(20,137)

 

(11,295)

Adjustments to contingent consideration

(1,500)

 

Interest accretion expense

 

863

 

1,986

Foreign currency translation adjustment

 

10

 

Ending balance

$

75,262

$

117,733